Published in Oncotarget on July 19, 2016
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 15.90
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2003) 7.57
Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell (2004) 6.44
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell (2002) 6.05
Control mechanism of the circadian clock for timing of cell division in vivo. Science (2003) 5.92
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75
mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol (2011) 2.20
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab (2010) 1.63
Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol (2010) 1.58
Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab (2013) 1.47
Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med (2011) 1.37
NONO couples the circadian clock to the cell cycle. Proc Natl Acad Sci U S A (2012) 1.34
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer (2008) 1.26
Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle. Proc Natl Acad Sci U S A (2014) 1.11
Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors. PLoS One (2013) 1.07
RAS mutations in thyroid cancer. Oncologist (2013) 1.00
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma. Anticancer Res (2011) 0.99
Analysis options for high-throughput sequencing in miRNA expression profiling. BMC Res Notes (2014) 0.96
Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res (2003) 0.96
How to define follicular thyroid carcinoma? Virchows Arch (2006) 0.93
Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy. FEBS J (2015) 0.90
Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. PLoS One (2012) 0.90
Array-based diagnostic gene-expression score for atopy and asthma. J Allergy Clin Immunol (2002) 0.90
Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21. Oncotarget (2014) 0.89
Molecular signatures of thyroid follicular neoplasia. Endocr Relat Cancer (2010) 0.88
Human peripheral clocks: applications for studying circadian phenotypes in physiology and pathophysiology. Front Neurol (2015) 0.88
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules. J Transl Med (2012) 0.86
Thyroid circadian timing: roles in physiology and thyroid malignancies. J Biol Rhythms (2014) 0.85
Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol (2005) 0.85
Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol (2005) 0.84
Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing. Anticancer Res (2015) 0.83
Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol (2014) 0.82
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. J Pathol (2008) 0.82
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. Eur J Endocrinol (2015) 0.80
Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis. Oncotarget (2015) 0.79
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. Int J Cancer (2013) 0.79
Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy. Chronobiol Int (2014) 0.78
Proteome analysis in thyroid pathology. Expert Rev Proteomics (2015) 0.77
Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications? Thyroid (2015) 0.77
The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study. Thyroid Res (2015) 0.76